Advisors Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.41M Sell
174,647
-3,147
-2% -$62.4K 0.05% 461
2026
Q1
$3.42M Buy
177,794
+4,288
+2% +$84.5K 0.06% 432
2025
Q4
$3.29M Buy
173,506
+3,748
+2% +$69.5K 0.06% 440
2025
Q3
$3.16M Sell
169,758
-13,431
-7% -$251K 0.05% 452
2025
Q2
$3.38M Buy
183,189
+6,312
+4% +$112K 0.06% 428
2025
Q1
$3.09M Buy
176,877
+16,886
+11% +$285K 0.06% 445
2024
Q4
$2.77M Buy
159,991
+47
+0% +$858 0.05% 478
2024
Q3
$2.98M Buy
159,944
+4,036
+3% +$68K 0.05% 450
2024
Q2
$2.4M Buy
155,908
+2,419
+2% +$34.6K 0.05% 488
2024
Q1
$2.27M Sell
153,489
-20,126
-12% -$279K 0.04% 515
2023
Q4
$2.48M Sell
173,615
-25,764
-13% -$366K 0.05% 459
2023
Q3
$2.78M Sell
199,379
-22,525
-10% -$288K 0.06% 397
2023
Q2
$2.61M Sell
221,904
-5,985
-3% -$68.1K 0.05% 431
2023
Q1
$2.62M Buy
227,889
+4,525
+2% +$56K 0.05% 433
2022
Q4
$2.78M Buy
223,364
+30,331
+16% +$387K 0.06% 401
2022
Q3
$2.53M Buy
193,033
+21,243
+12% +$314K 0.05% 428
2022
Q2
$2.4M Buy
171,790
+18,049
+12% +$241K 0.04% 457
2022
Q1
$2.29M Buy
153,741
+39,170
+34% +$536K 0.04% 545
2021
Q4
$1.55M Buy
114,571
+13,161
+13% +$186K 0.02% 699
2021
Q3
$1.49M Buy
101,410
+10,799
+12% +$182K 0.02% 688
2021
Q2
$1.65M Sell
90,611
-17,352
-16% -$309K 0.02% 657
2021
Q1
$1.87M Sell
107,963
-6,465
-6% -$114K 0.03% 616
2020
Q4
$1.99M Sell
114,428
-31,244
-21% -$499K 0.03% 558
2020
Q3
$2.01M Sell
145,672
-15,941
-10% -$234K 0.04% 468
2020
Q2
$2.33M Sell
161,613
-8,603
-5% -$113K 0.05% 404
2020
Q1
$1.86M Buy
170,216
+30,882
+22% +$569K 0.04% 428
2019
Q4
$2.97M Buy
139,334
+36,307
+35% +$813K 0.05% 403
2019
Q3
$2.37M Buy
103,027
+45,455
+79% +$970K 0.04% 476
2019
Q2
$1.13M Buy
57,572
+24,825
+76% +$484K 0.02% 733
2019
Q1
$638K Buy
32,747
+5,577
+21% +$106K 0.01% 933
2018
Q4
$448K Buy
27,170
+4,607
+20% +$92.7K 0.01% 1006
2018
Q3
$522K Buy
22,563
+2,740
+14% +$62.1K 0.01% 1047
2018
Q2
$431K Sell
19,823
-5,399
-21% -$105K 0.01% 1089
2018
Q1
$426K Sell
25,222
-1,316
-5% -$23.2K 0.01% 1084
2017
Q4
$498K Sell
26,538
-20,709
-44% -$412K 0.01% 1076
2017
Q3
$1.04M Buy
47,247
+27,223
+136% +$615K 0.02% 846
2017
Q2
$483K Buy
20,024
+382
+2% +$9.71K 0.01% 1110
2017
Q1
$549K Sell
19,642
-5,289
-21% -$139K 0.01% 1068
2016
Q4
$609K Buy
24,931
+4,612
+23% +$106K 0.01% 1042
2016
Q3
$512K Buy
20,319
+5,986
+42% +$143K 0.01% 1084
2016
Q2
$296K Buy
14,333
+1,299
+10% +$27.1K ﹤0.01% 1253
2016
Q1
$262K Buy
13,034
+4,924
+61% +$94.4K ﹤0.01% 1258
2015
Q4
$164K Sell
8,110
-505
-6% -$10.6K ﹤0.01% 1434
2015
Q3
$200K Buy
8,615
+1,463
+20% +$37.3K ﹤0.01% 1374
2015
Q2
$184K Buy
7,152
+3,351
+88% +$95.1K ﹤0.01% 1394
2015
Q1
$126K Buy
+3,801
New +$123K ﹤0.01% 1453

Other funds holding SBRA

Advisors Asset Management's SBRA Position: Q2 2026 in Review

Advisors Asset Management reduced its Sabra Healthcare REIT (SBRA) stake by 1.8% in Q2 2026, selling an estimated $62.4K and leaving 174,647 shares worth $3.41M. The position accounts for 0.05% of the portfolio, ranked #461.

Advisors Asset Management first reported a position in SBRA in Q1 2015 and has held it in 46 quarters since. The position peaked at $3.42M in Q1 2026. 463 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Advisors Asset Management held 174,647 shares of Sabra Healthcare REIT worth $3.41M as of Q2 2026.
  • Advisors Asset Management sold 3,147 Sabra Healthcare REIT shares in Q2 2026, an estimated $62.4K.
  • Sabra Healthcare REIT made up 0.05% of Advisors Asset Management's portfolio in Q2 2026, its #461 holding.
  • Advisors Asset Management first reported a position in Sabra Healthcare REIT in Q1 2015 and has held it in 46 quarters since.
  • Advisors Asset Management's Sabra Healthcare REIT position peaked at $3.42M in Q1 2026.
  • 463 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.